Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


08.08.2022

1 Acta Anaesthesiol Scand
1 Am Heart J
4 Am J Cardiol
1 Am J Emerg Med
1 Arterioscler Thromb Vasc Biol
5 Catheter Cardiovasc Interv
2 Circ Cardiovasc Interv
1 Circ Genom Precis Med
2 Circ Heart Fail
1 Circ J
1 Circ Res
2 Clin Cardiol
1 Clin Chem
4 Heart
4 Hypertension
2 Int J Cardiol
4 J Am Coll Cardiol
1 J Electrocardiol
2 JAMA
6 N Engl J Med
2 PLoS One
1 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Anaesthesiol Scand

  1. PARVIAINEN MK, Vahtera A, Anas N, Tahtinen J, et al
    Anti-factor X Activity Levels with Continuous Intravenous Infusion and Subcutaneous Administration of Enoxaparin after Coronary Artery Bypass Grafting: a Randomized Clinical Trial.
    Acta Anaesthesiol Scand. 2022 Jul 30. doi: 10.1111/aas.14122.
    PubMed         Abstract available


    Am Heart J

  2. LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al
    The trial to assess chelation therapy 2 (TACT2): Rationale and design.
    Am Heart J. 2022;252:1-11.
    PubMed         Abstract available


    Am J Cardiol

  3. SMILOWITZ NR, Carey EP, Shah B, Hartigan PM, et al
    Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Am J Cardiol. 2022 Jul 30. pii: S0002-9149(22)00699.
    PubMed         Abstract available

  4. MEDLING T, Gobeil K, Sawalha K, Abozenah M, et al
    Relation of Patient's Opinion of Alcohol's Health Effects and Drinking Habits Among Hospitalized Patients With Cardiovascular Disease.
    Am J Cardiol. 2022 Jul 29. pii: S0002-9149(22)00716.
    PubMed         Abstract available

  5. MARINO M, Digiacomo S, Cacucci M, Catanoso A, et al
    Complete Percutaneous Revascularization in Patients Aged >/=85 Years With Acute Coronary Syndrome and Multivessel Coronary Artery Disease.
    Am J Cardiol. 2022 Jul 26. pii: S0002-9149(22)00700.
    PubMed         Abstract available

  6. OSEI AD, Mirbolouk M, Dardari Z, Shea S, et al
    A Simple Approach to the Identification of Guideline-Based Coronary Artery Calcium Score Percentiles (From the Multi-Ethnic Study of Atherosclerosis).
    Am J Cardiol. 2022 Jul 25. pii: S0002-9149(22)00641.
    PubMed         Abstract available


    Am J Emerg Med

  7. LIN YT, Ho MP
    Tranexamic acid for treatment of tenecteplase related hemorrhagic conversion.
    Am J Emerg Med. 2022 Jul 21. pii: S0735-6757(22)00482.
    PubMed        


    Arterioscler Thromb Vasc Biol

  8. WANG M, Wang Z, Lee Y, Lai HTM, et al
    Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study.
    Arterioscler Thromb Vasc Biol. 2022 Aug 1:ATVBAHA121316533.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  9. DI MARIO C, Kucukseymen S
    Second generation drug eluting stent: The longer, the better?
    Catheter Cardiovasc Interv. 2022;100:188-189.
    PubMed        

  10. GUO J, Ning Y, Wu S, Zhang F, et al
    Risk factors for in-stent restenosis after vertebral artery stenting of V1 segment: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022;100:279-289.
    PubMed         Abstract available

  11. MENNUNI MG, Solli M, Galiffa V, Patti G, et al
    Unmasking of a significant left main stenosis in a patient with high left ventricular pressures.
    Catheter Cardiovasc Interv. 2022;100:216-218.
    PubMed         Abstract available

  12. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    PubMed         Abstract available

  13. GAUTIER A, Hovasse T, Arroyo D, Unterseeh T, et al
    Safety and efficacy of 48 mm Xience Xpedition everolimus-eluting stent for the treatment of long coronary lesions.
    Catheter Cardiovasc Interv. 2022;100:179-187.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  14. OBAYASHI Y, Watanabe H, Morimoto T, Yamamoto K, et al
    Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort.
    Circ Cardiovasc Interv. 2022 Aug 1:CIRCINTERVENTIONS122012004.
    PubMed         Abstract available

  15. FEENSTRA RGT, Boerhout CKM, Woudstra J, Vink CEM, et al
    Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries.
    Circ Cardiovasc Interv. 2022 Jul 29:CIRCINTERVENTIONS122012017.
    PubMed         Abstract available


    Circ Genom Precis Med

  16. KIFLEN M, Le A, Mao S, Lali R, et al
    Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention.
    Circ Genom Precis Med. 2022 Jul 29:101161CIRCGEN121003423.
    PubMed         Abstract available


    Circ Heart Fail

  17. BEDROUNI W, Sharma A, Pitt B, Lam CSP, et al
    Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction.
    Circ Heart Fail. 2022 Aug 4:101161CIRCHEARTFAILURE121009295.
    PubMed        

  18. CHANG SA, Khakh P, Janzen M, Lee T, et al
    Trending Cardiac Biomarkers During Pregnancy in Women With Cardiovascular Disease.
    Circ Heart Fail. 2022 Jul 29:101161CIRCHEARTFAILURE121009018.
    PubMed         Abstract available


    Circ J

  19. MIZUTANI H, Fujimoto N, Ito H, Sato T, et al
    Prognostic Impact of Peak Aortic Jet Velocity on Patients With Acute Myocardial Infarction.
    Circ J. 2022 Jul 16. doi: 10.1253/circj.CJ-22-0217.
    PubMed         Abstract available


    Circ Res

  20. PEI J, Cai L, Wang F, Xu C, et al
    LPA2 Contributes to Vascular Endothelium Homeostasis and Cardiac Remodeling After Myocardial Infarction.
    Circ Res. 2022 Aug 3:101161CIRCRESAHA122321036.
    PubMed         Abstract available


    Clin Cardiol

  21. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    PubMed         Abstract available

  22. NAAMI R, Naami E, Omari T, Lowi SG, et al
    Cardiac rehabilitation performance predicts 1-year major adverse cardiovascular events.
    Clin Cardiol. 2022 Jul 29. doi: 10.1002/clc.23890.
    PubMed         Abstract available


    Clin Chem

  23. AAKRE KM, Saenger AK, Body R, Collinson P, et al
    Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-Markers.
    Clin Chem. 2022;68:1022-1030.
    PubMed         Abstract available


    Heart

  24. CIMCI M, Polad J, Mamas M, Iniguez-Romo A, et al
    Outcomes and regional differences in practice in a worldwide coronary stent registry.
    Heart. 2022 Jan 10. pii: heartjnl-2021-320116. doi: 10.1136/heartjnl-2021-320116
    PubMed         Abstract available

  25. KIM JH, Park J, Yang Y, Lee S, et al
    Percutaneous coronary intervention in patients with documented coronary vasospasm during long-term follow-up.
    Heart. 2022 Mar 22. pii: heartjnl-2021-320645. doi: 10.1136/heartjnl-2021-320645
    PubMed         Abstract available

  26. MCDERMOTT M, Bing R
    Coronary vasospasm and future percutaneous coronary intervention: relax.
    Heart. 2022 Apr 12. pii: heartjnl-2022-320974. doi: 10.1136/heartjnl-2022-320974
    PubMed        

  27. OTTO CM
    Heartbeat: long-term outcomes in patients with symptomatic coronary artery spasm.
    Heart. 2022;108:1247-1249.
    PubMed        


    Hypertension

  28. GIORGIONE V, Jansen G, Kitt J, Ghossein-Doha C, et al
    Peripartum and Long-Term Maternal Cardiovascular Health After Preeclampsia.
    Hypertension. 2022 Jul 29:101161HYPERTENSIONAHA12218730.
    PubMed         Abstract available

  29. CRUZ-LOPEZ EO, Ye D, Wu C, Lu HS, et al
    Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease.
    Hypertension. 2022 Jul 29:101161HYPERTENSIONAHA12218731.
    PubMed         Abstract available

  30. PICONE DS, Stoneman E, Cremer A, Schultz MG, et al
    Sex Differences in Blood Pressure and Potential Implications for Cardiovascular Risk Management.
    Hypertension. 2022 Aug 1:HYPERTENSIONAHA12219693.
    PubMed         Abstract available

  31. CLARK CE, Warren FC, Boddy K, McDonagh STJ, et al
    Higher Arm Versus Lower Arm Systolic Blood Pressure and Cardiovascular Outcomes: a Meta-Analysis of Individual Participant Data From the INTERPRESS-IPD Collaboration.
    Hypertension. 2022 Aug 2:HYPERTENSIONAHA12118921.
    PubMed         Abstract available


    Int J Cardiol

  32. GRAZIANI F, Lillo R, Biagini E, Limongelli G, et al
    Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01116.
    PubMed         Abstract available

  33. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01120.
    PubMed         Abstract available


    J Am Coll Cardiol

  34. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
    Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
    J Am Coll Cardiol. 2022;80:565-578.
    PubMed         Abstract available

  35. KALOGEROPOULOS AP, Butler J
    Worsening Cardiovascular Disease Epidemiology in the United States: The Time for Preparation Is Now.
    J Am Coll Cardiol. 2022;80:579-583.
    PubMed        

  36. ROTH GA, Vaduganathan M, Mensah GA
    Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:631-640.
    PubMed         Abstract available

  37. BEERI R
    Ischemic Mitral Regurgitation and Leaflet Remodeling: Another Arrow Hits the Target.
    J Am Coll Cardiol. 2022;80:511-512.
    PubMed        


    J Electrocardiol

  38. LAHTI R, Rankinen J, Lyytikainen LP, Eskola M, et al
    High-risk ECG patterns in ST elevation myocardial infarction for mortality prediction.
    J Electrocardiol. 2022;74:13-19.
    PubMed         Abstract available


    JAMA

  39. CIPOLLETTA E, Tata LJ, Nakafero G, Avery AJ, et al
    Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.
    JAMA. 2022;328:440-450.
    PubMed         Abstract available

  40. ANDERSON JL, Knowlton KU
    Cardiovascular Events and Gout Flares.
    JAMA. 2022;328:425-426.
    PubMed        


    N Engl J Med

  41. ORTIZ A
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:472.
    PubMed        

  42. WANG M, Zhou M, Feng Z
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:472-473.
    PubMed        

  43. SCHUERMANS A, Lewandowski AJ
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:473.
    PubMed        

  44. JACOBS DR JR, Sinaiko AR, Woo JG
    Childhood Risk Factors and Adult Cardiovascular Events. Reply.
    N Engl J Med. 2022;387:473-474.
    PubMed        

  45. HEYMAN SN, Abassi Z
    Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;387:477-478.
    PubMed        

  46. LESLIE BR, Gerwin LE
    Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;387:478.
    PubMed        


    PLoS One

  47. UDESEN NLJ, Helgestad OKL, Josiassen J, Hassager C, et al
    Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock.
    PLoS One. 2022;17:e0272279.
    PubMed         Abstract available

  48. CHOI SY, Rha SW, Cha J, Byun JK, et al
    Association of air pollution and 1-year clinical outcomes of patients with acute myocardial infarction.
    PLoS One. 2022;17:e0272328.
    PubMed         Abstract available


    Thromb Haemost

  49. BAMPATSIAS D, Mavroeidis I, Tual-Chalot S, Vlachogiannis NL, et al
    Beta-secretase-1 antisense RNA is associated with vascular ageing and atherosclerotic cardiovascular disease.
    Thromb Haemost. 2022 Aug 1. doi: 10.1055/a-1914-2094.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: